Cadre Holdings welcomes Debbie DeCotis to its Board as Independent Director

– USA, FL –  Cadre Holdings, Inc. (NYSE: CDRE), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, today announced the appointment of Debbie DeCotis to its Board as an Independent Director, effective immediately, expanding the Board to five members, of whom four are independent.

“We are thrilled to welcome Debbie to our board and will benefit greatly from her deep experience and leadership. I have known Debbie for over 20 years and have found her to be a constructive, collaborative and thoughtful voice in guiding the organizations in which she is involved. We look forward to working with her and the entire board as Cadre continues to execute on its strategic and growth objectives,” said CEO and Chairman, Warren Kanders.

Ms. DeCotis will also join the Compensation Committee.

About Deborah DeCotis

Debbie DeCotis has over 45 years of financial, advisory, and business operations experience with a successful track record of leadership across multiple global institutions and industries. She currently serves as Advisory Director at Morgan Stanley & Co., Inc. where she began her career in 1974 and rose to the position of Managing Director, serving as Head of Firm Communications and Managing Director and Co-Head of Global Debt Origination, amongst other roles. She later served as an EVP with Sotheby’s Holdings, Inc, managing aspects of the business related to finance, operations, and strategic planning.

Ms. DeCotis has extensive board-level governance experience at a variety of profit and non-profit organizations. Presently she is serving as Chair of the PIMCO Closed-End Funds Board as well as being a Director of Virtus Funds. Previously DeCotis served on the Board of Directors of Sotheby’s Holdings, Inc., Watford, RE Ltd., a specialty insurance and reinsurance company, and Armor Holding, Inc., a predecessor of Cadre.

Amongst her non-profit activities, Ms. DeCotis serves as a Board Trustee for Smith College, including serving on the Audit and Finance Committee, and as Chair of the Smith College Investment Committee. Ms. DeCotis previously also served as a Trustee of Stanford University, a Trustee of the Stanford Business School Trust, a Trustee of the Helena Rubenstein Foundation, as well as Co-Chair of the Special Projects Committee for Memorial Sloan Kettering. Ms. DeCotis is also a Member of the Council on Foreign Relations.

Ms. DeCotis said, “I am excited to join Cadre’s board and work again with Warren Kanders and other team members at such an important time for the Company. This appointment is a tremendous opportunity to be a part of Cadre’s continued growth trajectory and help support long-term value creation for all stakeholders.”

Ms. DeCotis received her M.B.A from Stanford’s Graduate School of Business and graduated from Smith College.

About Cadre

Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety and survivability products for first responders. Cadre’s equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company’s core products include body armor, explosive ordnance disposal equipment, and duty gear. Our highly engineered products are utilized in over 100 countries by federal, state, and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Our key brands include Safariland and Med-Eng, amongst others.

For more information: https://www.cadre-holdings.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.